EMulate Therapeutics

EMulate has solved one of medicine’s most elusive challenges: delivering therapeutic benefits without physical drugs. Here’s how:

Every molecule, including medicines, creates unique electromagnetic “fingerprints” as it moves. Think of it like each drug having its own song.

EMulate uses ultra-sensitive equipment to record these molecular songs, then plays them back to patients using safe, low-energy radio waves through a simple wearable device. The result is the body responding as if it’s received the actual medication, but without any chemicals entering its system.

EMulate’s technology can play a role in pain management, mental health, even cancer treatment. The company has multiple trials for pain and mental health starting soon and is aiming for the commercial launch of its technology in 2027.

Team Background

Chris Rivera - President & CEO

Kyle Kingma - Chief Financial Officer

Co-Investors